MoneyWorks4Me

A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 514.00 millions against Rs. 512.69 millions during year ago period.The Company's Net profit for the June 2022 quarter have declined marginally to Rs. 38.67  millions as against Rs. 53.97 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 64.66 millions from 83.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 514.00 512.69 0.26 514.00 512.69 0.26 2196.63 2448.05 -10.27
Other Income 29.80 13.31 123.89 29.80 13.31 123.89 119.93 71.41 67.95
PBIDT 64.66 83.29 -22.37 64.66 83.29 -22.37 314.56 449.80 -30.07
Interest 5.04 1.89 166.67 5.04 1.89 166.67 13.55 2.71 400.00
PBDT 59.62 81.75 -27.07 59.62 81.75 -27.07 301.25 447.39 -32.67
Depreciation 9.95 9.71 2.47 9.95 9.71 2.47 39.48 40.35 -2.16
PBT 49.67 72.04 -31.05 49.67 72.04 -31.05 261.77 407.04 -35.69
TAX 11.00 18.07 -39.13 11.00 18.07 -39.13 63.86 115.32 -44.62
Deferred Tax 0.70 -0.06 -1266.67 0.70 -0.06 -1266.67 1.40 2.31 -39.39
PAT 38.67 53.97 -28.35 38.67 53.97 -28.35 197.91 291.72 -32.16
Equity 940.00 789.95 18.99 940.00 789.95 18.99 862.45 789.95 9.18
PBIDTM(%) 12.58 16.25 -22.57 12.58 16.25 -22.57 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..